Company news

Moberg Pharma AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi

October 5, 2026

Moberg Pharma's Terclara[®](MOB-015) launched in Israel

September 23, 2026

M O B A Network: Proposal for an up to SEK 11.3 million directed share issue in M.O.B.A. to secure obligations under its outstanding bonds

September 14, 2026

Moberg Pharma strengthens organization ahead of European launch

August 11, 2026

New number of shares and votes in Moberg Pharma AB (publ)

June 30, 2026

Moberg Pharma reports progress on commercial launch preparations

June 15, 2026

Notice of Annual General Meeting in Moberg Pharma AB (publ)

April 17, 2026

Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential

November 5, 2025

Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europe

November 5, 2025

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 19 decks. Every deck is listed under its year.